NUAK2 and diabetes mellitus: Based on its structural similarity with sorbitol, we investigated whether meglumine may stimulate SNARK levels and exert muscle-associated protective effects against metabolic syndrome or diabetes-associated conditions in a preclinical mouse model of insulin-resistant diabetes.